Advances and challenges in the treatment of esophageal cancer
Esophageal cancer (EC) is one of the most common cancers with high morbidity and mortality rates. EC includes two histological subtypes, namely esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). ESCC primarily occurs in East Asia, whereas EAC occurs in Western countries....
Guardado en:
Autores principales: | Shiming He, Jian Xu, Xiujun Liu, Yongsu Zhen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9eca37b54fe44c4b85dd7c58d9a19ab3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
por: Hongfu Cai, et al.
Publicado: (2021) -
Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
por: Ruijie Zeng, et al.
Publicado: (2021) -
Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
por: Zongdan Jiang, et al.
Publicado: (2021) -
3D Organoids: An Untapped Platform for Studying Host–Microbiome Interactions in Esophageal Cancers
por: Samuel Flashner, et al.
Publicado: (2021) -
Esophageal cancer principles and practice /
Publicado: (2009)